Relmada Therapeutics Inc (NASDAQ:RLMD)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 0.66. At the close of
In last trading session, Relmada Therapeutics Inc (NASDAQ:RLMD) saw 1.28 million shares changing hands with its beta currently measuring 0.62. Company’s recent per share price
During the last session, Relmada Therapeutics Inc (NASDAQ:RLMD)’s traded shares were 0.21 million, with the beta value of the company hitting 0.66. The 52-week high
During the last session, Relmada Therapeutics Inc (NASDAQ:RLMD)’s traded shares were 0.58 million, with the beta value of the company hitting 0.62. At the end
In today’s recent session, 0.48 million shares of the Relmada Therapeutics Inc (NASDAQ:RLMD) have been traded, and its beta is 0.56. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne